| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/20/2002 | WO2002047727A1 Therapeutic agent comprising a b-subunit of a protein toxin |
| 06/20/2002 | WO2002047712A2 Peptide yy and peptide yy agonists for treatment of metabolic disorders |
| 06/20/2002 | WO2002047698A1 Remedies for dermatophytosis |
| 06/20/2002 | WO2002047697A2 Fractions of snake blood, their preparation and use as therapeutic agents |
| 06/20/2002 | WO2002047694A1 Pharmaceutical compositions for treatment of digestive disorders and associated diseases |
| 06/20/2002 | WO2002047612A2 Dietary supplement compositions |
| 06/20/2002 | WO2002047534A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/20/2002 | WO2002031110A3 Hematopoietic stem cell gene therapy |
| 06/20/2002 | WO2002030320A3 Stimulation of thymus for vaccination development |
| 06/20/2002 | WO2002028406A3 Induction of blood vessel formation by polynucleotides encoding sphingosine kinases |
| 06/20/2002 | WO2002014474A3 Method of treating alzheimer's disease with cell therapy |
| 06/20/2002 | WO2002008751A8 Mild enrichment of foetal cells from peripheral blood and use thereof |
| 06/20/2002 | WO2002003910A3 Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation |
| 06/20/2002 | WO2001095831A3 Cardiac disease treatment and device |
| 06/20/2002 | WO2001094541A3 Human mesenchymal progenitor cell |
| 06/20/2002 | WO2001090152A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/20/2002 | WO2001088104A3 Neural progenitor cell populations |
| 06/20/2002 | WO2001076612A8 METHOD FOR PRODUCING NEMATOCIDAL COMPOSITION BY HEAT TREATING A pH-ADJUSTED FERMENTATION BROTH |
| 06/20/2002 | WO2001060857A3 Compositions useful for regulating parkin gene activity |
| 06/20/2002 | WO2000077233A9 Complement-resistant non-mammalian dna viruses and uses thereof |
| 06/20/2002 | US20020077313 Methods and compositions for the diagnosis and treatment of cancer |
| 06/20/2002 | US20020077276 Administering blood or soluble-receptor containing fraction to a mammal suffering from an acute inflammatory condition, wherein prior to administration blood has been contacted with tetracycline or a tetracycline-like compound |
| 06/20/2002 | US20020076816 Generating preferential stemm cells; obtain cells, expose to activated egg extract, culture, monitor differentiation |
| 06/20/2002 | US20020076810 Biocompatible composition in the form of a gel for use in the treatment of, inflammation,tumors and bone disorders |
| 06/20/2002 | US20020076798 Liver-specific gene expression cassettes, and methods of use |
| 06/20/2002 | US20020076796 2786, a novel human aminopeptidase |
| 06/20/2002 | US20020076793 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 06/20/2002 | US20020076766 Novel glucosaminidase |
| 06/20/2002 | US20020076730 Cell culltures for use in detcetion, evaluation and treatment of bone disorders |
| 06/20/2002 | US20020076446 Novel medicinal herbal composition for treating liver diseases and HIV |
| 06/20/2002 | US20020076445 Eukaryotic cells and method for preserving cells |
| 06/20/2002 | US20020076419 Ligands added to adenovirus fiber |
| 06/20/2002 | US20020076418 Use of strains of parapoxvirus ovis against organ fibrosis |
| 06/20/2002 | US20020076412 Administering polypeptides derived from human myelin basic protein; for treatment of autoimmune diseases, multiple sclerosis |
| 06/20/2002 | US20020076410 Administrating antigens for passive immunization against pathogens in dairy cows (and other milk producing mammals) |
| 06/20/2002 | US20020076407 Method for selectively stimulating proliferation of t cells |
| 06/20/2002 | US20020076400 Adipose-derived stem cells and lattices |
| 06/20/2002 | US20020076395 Modified adipose tissue and related implants and methods |
| 06/20/2002 | US20020076392 Non-antibody immunomodulatory molecules such as cytokines expressed as membrane-bound fusion proteins; vaccines; immunotherapy |
| 06/20/2002 | DE10108264A1 Stammzellen, Verfahren zu deren Expansion in vitro sowie deren Verwendung Stem cells, method for their expansion in vitro and the use thereof |
| 06/20/2002 | CA2447900A1 Drug delivery compositions and medical devices containing block copolymer |
| 06/20/2002 | CA2445091A1 Pharmaceutical compositions for treatment of digestive disorders and associated diseases |
| 06/20/2002 | CA2434915A1 Therapeutic agent comprising a b-subunit of a protein toxin |
| 06/20/2002 | CA2431800A1 Peptide yy and peptide yy agonists for treatment of metabolic disorders |
| 06/20/2002 | CA2431107A1 Antitumoral carbazoles |
| 06/20/2002 | CA2429952A1 Method for generating immortal dendritic cell lines |
| 06/19/2002 | EP1215497A1 Diagnostics for transmissible spongiform encephalopathy |
| 06/19/2002 | EP1215212A2 Dihydro derivatives of LL-E33288 antibiotics |
| 06/19/2002 | EP1214945A2 Method and medicament for inhibiting the expression of a defined gene |
| 06/19/2002 | EP1214943A1 T-cell therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products |
| 06/19/2002 | EP1214894A1 Food formulations with a high calcium content |
| 06/19/2002 | EP1214453A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 06/19/2002 | EP1214443A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 06/19/2002 | EP1214440A2 Sequence-specific dna recombination in eukaryotic cells |
| 06/19/2002 | EP1214416A2 Use of replication-deficient adenoviral vector to boost cd8+ t cell immune response to antigen |
| 06/19/2002 | EP1214404A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 06/19/2002 | EP1214403A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 06/19/2002 | EP1214401A2 Dna encoding the human serine protease c-e |
| 06/19/2002 | EP1214397A2 Method for the selective protection of proliferating normal cells and the selective eradication of tumor cells having an inactive p53 pathway |
| 06/19/2002 | EP1214396A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 06/19/2002 | EP1214089A1 Therapeutic uses of m3 polypeptide |
| 06/19/2002 | EP1214084A2 An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 06/19/2002 | EP1214082A2 Methods and compositions for reducing immune response |
| 06/19/2002 | EP1214080A1 Glucosamine and egg for reducing inflammation |
| 06/19/2002 | EP1213971A1 Improving condition of elderly pets |
| 06/19/2002 | EP0814831B1 Medicaments for treatment of autoimmune diseases using interferon-tau |
| 06/19/2002 | EP0462215B1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS |
| 06/19/2002 | CN1354791A Compositions for treatment and diagnosis of breast cancer and methods for their use |
| 06/19/2002 | CN1354672A Composition comprising alkaline sphingomyelinase for use as dietetic preparation, food supplement or pharmaceutical product |
| 06/19/2002 | CN1354001A Prescription of medicine for curing heloma and planter wart |
| 06/19/2002 | CN1353994A Method for creating human/goat hemopoietic stem cell heteroplastic transplantation model |
| 06/19/2002 | CN1353993A Compounded medicine for curing dermatophytid infection |
| 06/19/2002 | CN1086301C Gargle for curing toothache |
| 06/19/2002 | CN1086298C Ointment for rheumatic spur |
| 06/19/2002 | CN1086297C Chinese medicinal pill for treating gynaopathy |
| 06/19/2002 | CN1086296C Compound donkey-hide gelatin preparation for preventing arrest of bone marrow in chemotherapy and radiotherapy and preparing method thereof |
| 06/19/2002 | CN1086294C Health care liquid and its preparation method |
| 06/19/2002 | CN1086292C Scorption and ant medicinal liquor |
| 06/18/2002 | US6407212 Method for the removal of causative agent(s) of transmissible spongiform encephalopathies from protein solutions |
| 06/18/2002 | US6407063 Tumor antigens and CTL clones isolated by a novel procedure |
| 06/18/2002 | US6406900 Flea protease proteins, nucleic acid molecules and uses thereof |
| 06/18/2002 | US6406861 Viral diseases and immunogens |
| 06/18/2002 | US6406839 Methods for using a plasma-like solution |
| 06/18/2002 | US6406707 Method for treatment of psoriasis |
| 06/18/2002 | US6406704 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 06/13/2002 | WO2002046458A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 06/13/2002 | WO2002046419A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 06/13/2002 | WO2002046401A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue |
| 06/13/2002 | WO2002046386A2 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 06/13/2002 | WO2002046376A1 Dehydrated antigen presenting cells usable for vaccination |
| 06/13/2002 | WO2002046375A1 In vitro synthesis of a layered cell sorted tissue |
| 06/13/2002 | WO2002046373A1 Method of collecting placental stem cells |
| 06/13/2002 | WO2002046225A2 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 06/13/2002 | WO2002046220A2 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 06/13/2002 | WO2002046210A1 Method for preparing tryptophan rich peptides |
| 06/13/2002 | WO2002045766A1 Tissue equivalant for transplantation and process for producing the same |
| 06/13/2002 | WO2002045737A2 Methods of treatment involving human mda-7 |
| 06/13/2002 | WO2002045736A1 Methods for improved diagnosis and treatment of mycobacterial infections |
| 06/13/2002 | WO2002045727A1 Lactic acid bacteria inhibiting adhesion of helicobacter pylori to gastric mucosa |
| 06/13/2002 | WO2002045726A1 Lactic acid bacteria with inhibiting activities on $(helicobacter pylori) |